Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class II · Moderate risk

CONTRAVE (naltrexone HCl and bupropion HCl)

Failed Tablet/Capsule Specifications: Potential tablet defect of broken tablets and/or equatorial splitting of the bilayer tablets into the two drug components.

Terminated Failed specification Takeda Pharmaceuticals North America, Inc. NDC 64764-890-99 D-1206-2015
Class II · Moderate risk

SUCRETS Sore Throat & Cough Vapor Cherry lozenges

Labeling: Label Mix-Up: An incorrect book label for Sucrets Sore Throat, Cough & Dry Mouth Honey Lemon lozenges was applied to the underside of the Sucrets Sore Throat & Cough Vapor Cherry lozenges tin.

Terminated Labeling / mix-up Medtech Products, Inc. D-1113-2015
Class II · Moderate risk

MD-Gastroview

Labeling: incorrect or missing lot number and/or expiration date

Terminated Labeling / mix-up Mallinckrodt, Inc. NDC 0019-4816-04 D-1132-2015
Class II · Moderate risk

Alprostadil

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1128-2015

Recalls by year